Articles from Labyrinth Psychiatry Group on depression, TMS, SPRAVATO/esketamine, anxiety, OCD, ADHD, and everyday mental health. They offer general education and do not replace an individual evaluation.
A plan for Thanksgiving, Hanukkah, Christmas and New Year’s 2026, how ordinary grief differs from prolonged grief disorder under the APA’s DSM-5-TR, when to contact a provider, and where Union County families can get help, including crisis lines.
No psilocybin treatment is FDA-approved yet, and New Jersey’s 2026 law funds research at three hospitals, not clinics. The approval timeline, what the studies found, who may not be a candidate, why not to try it on your own, and the options for hard-to-treat depression available now.
Symptoms that still run the day, an effect that fades by mid-afternoon, or little change at all. What NICE and the FDA labels say a right dose looks like, the signs of too low and too high, vitamin C and other look-alikes, and New Jersey’s follow-up rules for adult stimulants.
What a December of drinking does to mood, sleep and anxiety in the days after, what NIAAA, MedlinePlus and an FDA label say about alcohol with antidepressants, benzodiazepines, ADHD medication and lithium, holiday heart, the AUDIT-C questions, and how to raise it with your psychiatrist.
In 42 US practices, 58% of people responded to TMS and 37% reached remission. What response and remission mean, how soon TMS tends to work, how long it lasts, and why published rates run from 14% to 90%.
TMS is not FDA-cleared for bipolar depression, so it is used off-label. What a 2026 review of 56 studies found, how often mania happened, why trials kept people on a mood stabilizer, insurance, and how to ask about it at an evaluation in Cranford.
TMS is FDA-cleared for depression; no neurofeedback device was found cleared for it. How each works, what the research shows, session counts, side effects and insurance, side by side.
Five medicines are FDA-approved for OCD. Their label doses and ages, why OCD needs higher doses and 8 to 12 weeks, what to try if the first medicine does not work (a second SSRI, clomipramine, add-ons, ERP), and where TMS fits.
TMS can help depression that medication has not fixed, with no anesthesia and mostly mild side effects. The trade-offs: five visits a week for six to eight weeks, approval first on some plans, a rare seizure risk, and no guarantee. Each pro and con, with its source.
A psychiatrist is a medical doctor who can prescribe; a psychologist has a doctorate and cannot prescribe in New Jersey; a therapist is usually a master’s-level LCSW or LPC. The New Jersey licences, the nurse practitioner option, and which one to see first.
When antidepressants help only partly, stop helping, or cause side effects you cannot live with, TMS targets the brain circuits involved in depression without another systemic medication. How it works, what a course at our Cranford and Edison offices involves, and how we decide whether it is the next step.
Medicare’s 2026 rate is $220.41 for a first evaluation and $239.43 for a typical 30-minute follow-up in Northern New Jersey. The visit codes, your share with Medicare, a work plan or no insurance, and how to get your number first.
Medicare’s 2026 rate is $226 a session in Northern New Jersey. The CPT codes, what a full course totals, what Aetna, Cigna, UnitedHealthcare, Horizon, Medicare and TRICARE require, and your share.
On November 1, 2026 sunset in Cranford moves from 5:56 to 4:55 p.m. What the evidence says about light therapy, CBT-SAD and bupropion XL, and when a seasonal depression needs TMS or SPRAVATO.
Mental Illness Awareness Week ran October 4–10. What the week stood for, what the numbers say, and three things to do as a result of it: a conversation, an appointment, or a next-step question.
When standard antidepressants don’t provide enough relief, targeting a different brain pathway could help. Discover how Spravato® uses glutamate signaling to treat resistant depression.
If you’re struggling with depression that hasn’t improved with traditional medication, Spravato® could help. Read on to learn how this innovative nasal…
If you have had prior psychiatric treatment and continue to be depressed, your insurance may cover TMS treatment for you. Click on the above link for more…
Are you struggling with brain fog, memory lapses, and poor focus? Transcranial magnetic stimulation offers a non-invasive way to stimulate key areas of the…
Treatment-resistant depression is relentless and isolating. When nothing helps, it can leave you desperate, exhausted, and afraid you’ll never feel better.…
When depression doesn’t improve with standard treatments, new options like Spravato® can help. This easy-to-use esketamine nasal spray offers a different…
When depression doesn’t improve with standard treatment, esketamine therapy may offer a new path forward. Learn how it could help you and what to expect…
Treatment-resistant depression affects up to 30% of people with major depressive disorder. SPRAVATO® provides a safe, effective way to reduce symptoms and…
Seeing a loved one suffer from obsessive-compulsive disorder (OCD) can be heartbreaking, but you don’t have to sit on the sidelines. Learn how to support…
If you suffer from treatment-resistant depression (TRD), Spravato® may be able to provide lasting relief. When used alongside a traditional antidepressant…
Mental-health patient education from Labyrinth Psychiatry Group in Cranford, New Jersey. Treatment decisions are made through an individual clinical evaluation.
Many people with major depressive disorder (MDD) are exploring the benefits of transcranial magnetic stimulation (TMS). But is the treatment safe? This…
Transcranial magnetic stimulation (TMS) therapy is gaining popularity, but myths about the treatment abound. In this blog, we debunk common misconceptions and…
Adult ADHD can make daily life feel scattered, stressful, and exhausting. Learn how transcranial magnetic stimulation (TMS) offers a drug-free option for…
Thinking about TMS therapy for OCD? Learn how it works, what treatment feels like, and what you can expect on your journey toward better control of your…
Recent pharmaceutical trials for Psilocybin reveal much to be excited about in terms of a potential treatment for Major Depressive Disorder, but also leave a…
TMS therapy offers new hope for people with depression who haven’t found relief from medication. Learn how this noninvasive, drug-free treatment works to…
Up to 2.8 million Americans have treatment-resistant depression. SPRAVATO® is a groundbreaking treatment that can safely ease symptoms. Read on to learn more.
Depression and anxiety often occur together and can cause immense stress in your life. While you might be able to manage symptoms through behavior change and…
The holidays are lots of fun but they’re also stressful. Unfortunately, the added pressure can exacerbate mental health conditions like depression and…
You’ve tried one antidepressant after another, only to see no improvement in your symptoms. But what about Spravato®? This revolutionary new drug can help…